Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5281790
Max Phase: Preclinical
Molecular Formula: C40H67N17O11S4
Molecular Weight: 1090.35
Associated Items:
ID: ALA5281790
Max Phase: Preclinical
Molecular Formula: C40H67N17O11S4
Molecular Weight: 1090.35
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H]2CCC(=O)N2)C(=O)N1)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC1=O
Standard InChI: InChI=1S/C40H67N17O11S4/c1-3-18(2)29(38(68)56-26-17-70-69-14-23(30(42)60)53-36(26)66)57-34(64)22(8-10-27(41)58)52-32(62)19(6-4-12-47-39(43)44)50-31(61)20(7-5-13-48-40(45)46)51-35(65)24-15-71-72-16-25(37(67)55-24)54-33(63)21-9-11-28(59)49-21/h18-26,29H,3-17H2,1-2H3,(H2,41,58)(H2,42,60)(H,49,59)(H,50,61)(H,51,65)(H,52,62)(H,53,66)(H,54,63)(H,55,67)(H,56,68)(H,57,64)(H4,43,44,47)(H4,45,46,48)/t18-,19-,20-,21-,22-,23-,24-,25-,26-,29-/m0/s1
Standard InChI Key: HLUXTGTURXBMGU-DCBLBBIQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1090.35 | Molecular Weight (Monoisotopic): 1089.4089 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Brust A, Croker DE, Colless B, Ragnarsson L, Andersson Å, Jain K, Garcia-Caraballo S, Castro J, Brierley SM, Alewood PF, Lewis RJ.. (2016) Conopeptide-Derived κ-Opioid Agonists (Conorphins): Potent, Selective, and Metabolic Stable Dynorphin A Mimetics with Antinociceptive Properties., 59 (6): [PMID:26859603] [10.1021/acs.jmedchem.5b00911] |
Source(1):